Welcome to our dedicated page for Viavi Solutions SEC filings (Ticker: VIAV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Viavi Solutions Inc. (NASDAQ: VIAV) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures alongside AI‑generated summaries. As a global provider of network test, monitoring and assurance solutions and optical security and light management technologies, VIAVI uses its SEC reports to describe its segment performance, capital structure, governance and material events.
Investors can review annual reports on Form 10‑K and quarterly reports on Form 10‑Q for detailed information on the Network and Service Enablement and Optical Security and Performance Products segments, geographic revenue breakdowns, risk factors and management’s discussion and analysis. Current reports on Form 8‑K document significant developments such as the completion of the acquisition of Spirent Communications plc’s high-speed ethernet, network security and channel emulation testing business, entry into term loan and revolving credit agreements, issuance and exchange of Senior Convertible Notes, and share exchange transactions.
This page also surfaces filings related to corporate governance and shareholder matters, including the definitive proxy statement (DEF 14A) for the annual meeting of stockholders and amendments to the certificate of incorporation. Where applicable, Form 3, 4 and 5 insider transaction reports can be used to track trading activity by directors and officers.
Stock Titan’s AI features help interpret lengthy documents by highlighting key terms such as segment revenue trends, leverage and debt instruments, equity incentive plans, and amendments to governance documents. Real‑time updates from EDGAR ensure that new VIAV filings, from earnings‑related 8‑Ks to financing agreements, appear promptly with concise explanations of their significance.
Luke M. Scrivanich, SVP General Manager OSP at Viavi Solutions (VIAV), reported multiple routine equity transactions on 08/28/2025 tied to vesting and tax-withholding. Several restricted stock units (RSUs) and market stock units (MSUs) converted or vested, resulting in acquisitions totaling 45,611 shares from an MSU award and additional RSU conversions of 43,966 shares across installments. The reporting shows shares withheld by the company to cover tax obligations and 1,194 shares purchased under the ESPP. After these transactions, total beneficial ownership positions reported for common stock ranged up to 88,785 shares in aggregate for certain line items. The filing reflects routine compensation vesting and payroll tax settlements rather than open-market discretionary purchases.
Anthony Michael Petrucci, SVP and Chief Operations Officer of Viavi Solutions Inc. (VIAV), acquired equity awards on 08/28/2025 consisting of 36,982 Restricted Stock Units (RSUs) and 36,982 Market Stock Units (MSUs). Each award converts to one share of common stock for a combined total of 73,964 underlying shares following the reported transactions. The RSUs vest annually in three equal installments and the MSU vesting schedule and terms are referenced in an exhibit; both award types have no expiration dates. The holdings reported after the transactions are 36,982 RSUs and 36,982 MSUs held directly.
Paul McNab, EVP, Chief Marketing & Strategy Officer of Viavi Solutions Inc. (VIAV), reported equity transactions on 08/28/2025. The filing shows three installments of restricted stock units (RSUs) that converted upon vesting into 9,906, 12,879 and 18,739 shares; the company withheld 5,031, 6,540 and 9,517 shares to satisfy tax withholding at a stated price of $11.27 per share. The filing also reports an award of 44,378 RSUs and 44,378 market stock units (MSUs) granted on that date. Post-transaction beneficial ownership figures are listed for each line, for example 44,181, 39,150, 52,029, 45,489, 64,228 and 54,711 shares. The form is signed by an attorney-in-fact on 09/02/2025.
Ilan Daskal, EVP and CFO of Viavi Solutions (VIAV), received and settled equity awards tied to his compensation. On 08/28/2025, 55,115 restricted stock units (RSUs) converted into 55,115 shares of common stock and 24,857 shares were surrendered to the company to satisfy tax-withholding obligations from an RSU vesting, leaving 30,258 shares beneficially owned in the non-derivative table after the sale/withholding. The filing also reports outstanding equity awards: 110,228 RSU-equivalent shares reported following the conversion event and additional award balances of 142,258 RSUs and 142,258 market stock units (MSUs), each noted as having no expiration and vesting per the award schedules. The filing was signed by an attorney-in-fact on behalf of the reporting person.
Richard John Burns, a director of Viavi Solutions Inc. (VIAV), was granted 6,768 restricted stock units (RSUs) on 08/28/2025. The award carries a $0 purchase price and results in 6,768 shares of common stock beneficially owned following the transaction, held directly. The RSUs vest on the earlier of the one-year anniversary of the grant or the company’s next annual meeting of stockholders, and the RSUs have no expiration date. The Form 4 was signed by Donna T. Rossi as attorney-in-fact on 08/29/2025 and was filed as a single reporting person filing.
Viavi Solutions Inc. (VIAV) director Eugenia Corrales received an award of 6,768 restricted stock units (RSUs) on 08/28/2025. The RSUs were granted at a $0 exercise/conversion price and are reported as directly owned following the transaction, with 6,768 shares underlying the award. The units vest on the earlier of the one-year anniversary of the grant or the next annual meeting of stockholders, and the filing states there is no expiration date on the RSUs. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/29/2025.
Form 144 filed for Viavi Solutions Inc. (VIAV) shows a proposed sale of 13,115 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $146,560.13. The filing lists the number of outstanding shares as 223,245,915 and identifies the approximate date of sale as 08/29/2025 on NASDAQ. The securities were acquired on 08/28/2025 as restricted stock from the issuer, with payment dated 08/28/2025. The filer reports no securities sold in the past three months. The filing includes the standard representation that the seller is not aware of undisclosed material adverse information and notes reliance possibilities for a Rule 10b5-1 trading plan if applicable. The issuer name and some filer contact details are not provided in the visible content.
Viavi Solutions Inc. (VIAV) submitted a Form 144 notice for a planned sale of 11,873 common shares valued at $132,693.84, to be executed approximately on 08/29/2025 on the NASDAQ. The shares represent a small portion of the company's common stock, with 223,245,915 shares outstanding, and were acquired as restricted stock from the issuer on 08/28/2025. The filing reports no sales by the seller in the past three months and indicates the transaction will be brokered by Morgan Stanley Smith Barney LLC. The filer attests they are not aware of undisclosed material adverse information and notes the usual Rule 10b5-1/attestation language on trading plans and criminal penalties for misstatements.
Viavi Solutions Inc. filed an 8-K reporting a material event and furnished two exhibits: an indenture dated August 20, 2025 between the company and U.S. Bank Trust Company, National Association as trustee, and the form of 0.625% Senior Convertible Notes due 2031 (included as part of the indenture). The filing lists the company’s principal contact information and is signed by Ilan Daskal, Chief Financial Officer, as the duly authorized officer. The exhibits indicate the company has documented the legal framework and the note terms for a convertible debt instrument carrying a stated interest rate of 0.625% and a 2031 maturity.
Viavi Solutions Inc. entered into privately negotiated exchange and subscription agreements to issue $250 million aggregate principal amount of new 0.625% Senior Convertible Notes due 2031. The deal includes about $100.9 million of new notes issued in exchange for approximately $97.5 million of its 1.625% Senior Convertible Notes due 2026 and about $149.1 million of new notes sold for cash to institutional investors under Securities Act exemptions. The company will cancel the exchanged 2026 notes and receive gross cash proceeds of about $149.1 million before fees. The new notes are convertible into cash and, if applicable, common stock at an initial rate of 72.5295 shares per $1,000 principal (a conversion price of roughly $13.79 per share, a 25% premium to the $11.03 closing price on August 13, 2025), with a current maximum of 22,665,450 shares issuable upon conversion.